查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1869687

烟酰胺腺嘌呤二核苷酸市场规模、份额和趋势分析报告：按产品、分销管道、地区和细分市场预测（2025-2033 年）

Nicotinamide Adenine Dinucleotide Products Market Size, Share & Trends Analysis Report By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 109 Pages | 商品交期: 2-10个工作天内

价格

烟酰胺腺嘌呤二核苷酸产品市场摘要

2024 年全球烟碱酰胺腺嘌呤二核苷酸产品市场规模为 34.5116 亿美元，预计到 2033 年将达到 121.8724 亿美元。

预计从 2025 年到 2033 年，烟酰胺腺嘌呤二核苷酸 (NAD) 产品产业将以 15.1% 的复合年增长率成长。人们对 NAD 在细胞能量产生、DNA 修復和健康老龄化中的作用的认识不断提高，推动了 NAD 产品产业的成长。

随着人们对长寿和预防保健的日益关注，消费者正在寻求能够增强活力、改善认知功能和促进代谢健康的营养补充品。此外，将NAD水平与老龄化相关疾病联繫起来的持续研究也进一步推动了营养补充剂和健康市场的需求。

由于人们对健康老龄化和提升认知功能的兴趣日益浓厚，像NR（烟碱酰胺核苷）和NMN（烟碱酰胺单核苷酸）这样的NAD+补充剂越来越受欢迎。 Tru Niagen和Elysium Health等品牌抓住了这一趋势，推出了声称可以增强精力、提高注意力并帮助抵抗与老龄化相关的衰退的产品。

NAD产品的应用范围已不再局限于膳食补充剂，而是开始广泛应用于静脉输液、护肤和机能饮料等领域，逐渐被更广泛的消费者所熟知和接受。随着临床研究的不断深入和消费者需求的增长，NAD正成为蓬勃发展的健康和抗衰老领域的关键成分。例如，领先的代谢健康平台Eden于2025年5月开始透过远端医疗服务在全美销售其NAD+ 10%乳霜（需凭处方笺）。

NAD产品产业已远远超越了传统的口服补充剂，各大品牌都在探索新的给药方式，以提升功效、使用者体验和市场吸引力。虽然含有烟碱酰胺核苷（NR）和烟碱酰胺单核苷酸（NMN）等前体的胶囊和片剂仍然是主流，但脂质体配方、缓释片和舌下粉剂等新型製剂因其提高生物利用度的潜力而日益受到关注。这些创新不仅满足了消费者对更有效给药方式的需求，也有助于品牌在竞争激烈的市场中脱颖而出。

例如，2025年1月，Renue by Science推出了Renue Blue，这是一个专注于肌肤健康和延缓衰老的全新护肤系列，采用脂质体包裹的NAD（烟酰胺腺嘌呤二核苷酸）。该产品系列旨在利用NAD（一种对细胞功能至关重要的辅酶）的益处，将其作为促进肌肤健康的局部外用成分。脂质体递送系统旨在提高NAD在皮肤中的吸收率和功效。

目录

第一章调查方法和范围

第二章执行摘要

3. 烟酰胺腺嘌呤二核苷酸 (NAD) 产品市场变数与趋势

  • 市场发展
  • 产业价值链分析
    • 原料趋势及展望
    • 零售/销售管道分析
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会
    • 市场挑战
  • 产业分析工具
    • 波特五力分析
  • 打入市场策略

4. 烟酰胺腺嘌呤二核苷酸 (NAD) 产品市场：消费行为分析

  • 人口统计分析
  • 消费者趋势和偏好
  • 影响购买决策的因素
  • 消费者产品采纳
  • 观察与建议

5. 烟酰胺腺嘌呤二核苷酸 (NAD) 产品市场：按产品分類的估算和趋势分析

  • 重点
  • 产品差异分析及市占率（2024 年及 2033 年）
  • 按产品划分，2021-2033 年
    • 口服补充剂
    • 外用产品
    • 其他的

6. 烟酰胺腺嘌呤二核苷酸 (NAD) 产品市场：按分销管道分類的估算和趋势分析

  • 重点
  • 2024年及2033年通路变化分析及市场份额
  • 按分销管道划分，2021-2033 年
    • 大卖场和超级市场
    • 药房和药品商店
    • 在线的
    • 其他的

7. 烟酰胺腺嘌呤二核苷酸 (NAD) 产品市场：区域估算与趋势分析

  • 2024年及2033年区域动态分析及市场份额
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲和纽西兰
    • 台湾
    • 韩国
  • 拉丁美洲
    • 巴西
  • 中东和非洲
    • 阿拉伯聯合大公国

8. 烟酰胺腺嘌呤二核苷酸 (NAD) 产品市场：竞争分析

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 参与企业概况
  • 财务业绩
  • 产品基准测试
  • 公司市占率分析，2024 年（%）
  • 企业热力图分析，2024 年
  • 策略规划
  • 公司简介
    • Core Med Science
    • Niagen Bioscience, Inc.
    • Elysium Health
    • Thorne
    • Cata-Kor NAD
    • Life Extension
    • Wonderfeel
    • Nutricost
    • RENUE BY SCIENCE, Inc.
    • Codeage LLC
    • HPN SUPPLEMENTS
Product Code: GVR-4-68040-787-5

Nicotinamide Adenine Dinucleotide Products Market Summary

The global nicotinamide adenine dinucleotide products market size was valued at USD 3,451.16 million in 2024 and is expected to reach USD 12,187.24 million by 2033, growing at a CAGR of 15.1% from 2025 to 2033. The nicotinamide adenine dinucleotide (NAD) products industry is driven by increasing awareness of its role in cellular energy production, DNA repair, and healthy aging.

Consumers are seeking supplements that support vitality, cognitive function, and metabolic health, especially as interest in longevity and preventive wellness grows. Additionally, ongoing research linking NAD levels to age-related conditions has further fueled demand in the nutraceutical and wellness markets.

The popularity of NAD-boosting supplements like NR (Nicotinamide Riboside) and NMN (Nicotinamide Mononucleotide) has increased, driven by interest in healthy aging and cognitive support. Brands such as Tru Niagen and Elysium Health have capitalized on this trend, offering products that claim to enhance energy, focus, and resilience against age-related decline.

NAD products are also seeing wider use beyond supplements, appearing in IV therapy, skincare, and functional beverages, making them more accessible and appealing to a broader audience. As clinical research and consumer demand continue to grow, NAD is becoming a key ingredient in the evolving wellness and anti-aging space. For instance, in May 2025, Eden, a leading metabolic health platform, launched U.S.-wide access to a prescription-only NAD+ 10% Face Cream through its telehealth service.

The NAD products industry is expanding well beyond traditional oral supplements, with brands exploring new delivery formats to improve efficacy, user experience, and market appeal. While capsules and tablets containing precursors like Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN) remain the most common format, newer options such as liposomal formulations, sustained-release tablets, and sublingual powders are gaining popularity for their potential to enhance bioavailability. These innovations not only cater to consumer demand for more effective dosing but also allow brands to differentiate in a crowded market.

For instance, in January 2025, Renue by Science introduced a new skincare line called Renue Blue, which focuses on skin wellness and longevity through the use of liposomal NAD (Nicotinamide Adenine Dinucleotide). The product line aims to leverage the benefits of NAD, a coenzyme crucial for cellular functions, in a topical format to promote skin health. The liposomal delivery system is designed to enhance the absorption and effectiveness of NAD in the skin.

Nicotinamide Adenine Dinucleotide Products Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nicotinamide adenine dinucleotide products market report on the basis of product, distribution channel, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral Supplements
    • Capsules/Tablets
    • Powders
    • Energy Drinks
  • Topical Products
    • Creams & Serums
    • Eye Cream & Lip Balms
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hypermarkets & Supermarkets
  • Pharmacies & Drug Stores
  • Online
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Taiwan
    • South Korea
  • Central & South America
    • Brazil
  • Middle East & Africa
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Materials & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product Outlook
  • 2.3. Distribution Channel Outlook
  • 2.4. Regional Outlook
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Nicotinamide Adenine Dinucleotide (NAD) Products Market Variables and Trends

  • 3.1. Market Introduction
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Raw Material Trends & Outlook
    • 3.2.2. Retail/Sales Channel Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Consumer Behavior Analysis

  • 4.1. Demographic Analysis
  • 4.2. Consumer Trends & Preferences
  • 4.3. Factors Affecting Buying Decisions
  • 4.4. Consumer Product Adoption
  • 4.5. Observations & Recommendations

Chapter 5. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Product Estimates & Trend Analysis

  • 5.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, By Product: Key Takeaways
  • 5.2. Product Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Market Estimates & Forecasts by Product, 2021 - 2033 (USD Million)
    • 5.3.1. Oral Supplements
      • 5.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.1.1.1. Capsules/Tablets
          • 5.3.1.1.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.1.1.2. Powders
          • 5.3.1.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.1.1.3. Energy Drinks
          • 5.3.1.1.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.3.2. Topical Products
      • 5.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.2.1.1. Creams & Serums
          • 5.3.2.1.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
        • 5.3.2.1.2. Eye Cream & Lip Balms
          • 5.3.2.1.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 5.3.3. Others
      • 5.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, By Distribution Channel: Key Takeaways
  • 6.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Market Estimates & Forecasts, by Distribution Channel, 2021 - 2033 (USD Million)
    • 6.3.1. Hypermarkets & Supermarkets
      • 6.3.1.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.2. Pharmacies & Drug Stores
      • 6.3.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.3. Online
      • 6.3.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Movement Analysis & Market Share, 2024 & 2033
  • 7.2. North America
    • 7.2.1. U.S.
      • 7.2.1.1. Key country dynamics
      • 7.2.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.2.2. Canada
      • 7.2.2.1. Key country dynamics
      • 7.2.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.2.3. Mexico
      • 7.2.3.1. Key country dynamics
      • 7.2.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. U.K.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Key country dynamics
      • 7.3.2.3.Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.3. France
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.4. Italy
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Key country dynamics
      • 7.3.5.2. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. China
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.2. India
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.4. Australia & New Zealand
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.5. Taiwan
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.5. Central & South America
    • 7.5.1. Brazil
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. UAE
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Competitive Analysis

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Participant's Overview
  • 8.4. Financial Performance
  • 8.5. Product Benchmarking
  • 8.6. Company Market Share Analysis, 2024 (%)
  • 8.7. Company Heat Map Analysis, 2024
  • 8.8. Strategy Mapping
  • 8.9. Company Profiles
    • 8.9.1. Core Med Science
      • 8.9.1.1. Company Overview
      • 8.9.1.2. Financial Performance
      • 8.9.1.3. Product Portfolios
      • 8.9.1.4. Strategic Initiatives
    • 8.9.2. Niagen Bioscience, Inc.
      • 8.9.2.1. Company Overview
      • 8.9.2.2. Financial Performance
      • 8.9.2.3. Product Portfolios
      • 8.9.2.4. Strategic Initiatives
    • 8.9.3. Elysium Health
      • 8.9.3.1. Company Overview
      • 8.9.3.2. Financial Performance
      • 8.9.3.3. Product Portfolios
      • 8.9.3.4. Strategic Initiatives
    • 8.9.4. Thorne
      • 8.9.4.1. Company Overview
      • 8.9.4.2. Financial Performance
      • 8.9.4.3. Product Portfolios
      • 8.9.4.4. Strategic Initiatives
    • 8.9.5. Cata-Kor NAD
      • 8.9.5.1. Company Overview
      • 8.9.5.2. Financial Performance
      • 8.9.5.3. Product Portfolios
      • 8.9.5.4. Strategic Initiatives
    • 8.9.6. Life Extension
      • 8.9.6.1. Company Overview
      • 8.9.6.2. Financial Performance
      • 8.9.6.3. Product Portfolios
      • 8.9.6.4. Strategic Initiatives
    • 8.9.7. Wonderfeel
      • 8.9.7.1. Company Overview
      • 8.9.7.2. Financial Performance
      • 8.9.7.3. Product Portfolios
      • 8.9.7.4. Strategic Initiatives
    • 8.9.8. Nutricost
      • 8.9.8.1. Company Overview
      • 8.9.8.2. Financial Performance
      • 8.9.8.3. Product Portfolios
      • 8.9.8.4. Strategic Initiatives
    • 8.9.9. RENUE BY SCIENCE, Inc.
      • 8.9.9.1. Company Overview
      • 8.9.9.2. Financial Performance
      • 8.9.9.3. Product Portfolios
      • 8.9.9.4. Strategic Initiatives
    • 8.9.10. Codeage LLC
      • 8.9.10.1. Company Overview
      • 8.9.10.2. Financial Performance
      • 8.9.10.3. Product Portfolios
      • 8.9.10.4. Strategic Initiatives
    • 8.9.11. HPN SUPPLEMENTS
      • 8.9.11.1. Company Overview
      • 8.9.11.2. Financial Performance
      • 8.9.11.3. Product Portfolios
      • 8.9.11.4. Strategic Initiatives

List of Tables

  • Table 1 Global nicotinamide adenine dinucleotide (NAD) products market - Key market driver analysis
  • Table 2 Global nicotinamide adenine dinucleotide (NAD) products market - Key market restraint analysis
  • Table 3 Global nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by product (USD Million)
  • Table 4 Global nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 5 U.S macro-economic outlay
  • Table 6 U.S nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 7 U.S nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 8 U.S nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 9 Canada macro-economic outlay
  • Table 10 Canada nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 11 Canada nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 12 Canada nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 13 Mexico macro-economic outlay
  • Table 14 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 15 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 16 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 17 U.K macro-economic outlay
  • Table 18 U.K nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 19 U.K nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 20 U.K nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 21 Germany macro-economic outlay
  • Table 22 Germany nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 23 Germany nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 24 Germany nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 25 France macro-economic outlay
  • Table 26 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 27 France nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 28 France nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 29 Italy macro-economic outlay
  • Table 30 Italy nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 31 Italy nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 32 Italy nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 33 Spain macro-economic outlay
  • Table 34 Spain nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 35 Spain nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 36 Spain nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 37 China macro-economic outlay
  • Table 38 China nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 39 China nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 40 China nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 41 India macro-economic outlay
  • Table 42 India nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 43 India nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 44 India nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 45 Japan macro-economic outlay
  • Table 46 Japan Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 47 Japan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 48 Japan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 49 Australia & New Zealand macro-economic outlay
  • Table 50 Australia & New Zealand Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 51 Taiwan macro-economic outlay
  • Table 52 Taiwan Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 53 Taiwan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 54 Taiwan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 55 South Korea macro-economic outlay
  • Table 56 South Korea Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 57 South Korea nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 58 South Korea nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 59 Brazil macro-economic outlay
  • Table 60 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 61 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 62 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 63 UAE macro-economic outlay
  • Table 64 UAE nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Table 65 UAE nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)
  • Table 66 UAE nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)
  • Table 67 Recent developments & impact analysis by key market participants
  • Table 68 Company market share, 2024
  • Table 69 Company heat map analysis
  • Table 70 Companies undergoing key strategies

List of Figures

  • Fig. 1 Global Nicotinamide Adenine Dinucleotide (NAD) Products Market Segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary research approaches
  • Fig. 5 Primary research process
  • Fig. 6 Market snapshot
  • Fig. 7 Product snapshot
  • Fig. 8 Distribution Channel snapshot
  • Fig. 9 Regional snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Global nicotinamide adenine dinucleotide (NAD) products market size (USD Million)
  • Fig. 12 Global nicotinamide adenine dinucleotide (NAD) products market size, 2021 to 2033 (USD Million)
  • Fig. 13 Global nicotinamide adenine dinucleotide (NAD) products market: Penetration & growth prospect mapping
  • Fig. 14 Global nicotinamide adenine dinucleotide (NAD) products market: Value chain analysis
  • Fig. 15 Global nicotinamide adenine dinucleotide (NAD) products market: Profit margin analysis
  • Fig. 16 Global nicotinamide adenine dinucleotide (NAD) products market: Market dynamics
  • Fig. 17 Global nicotinamide adenine dinucleotide (NAD) products market: Porter's five forces analysis
  • Fig. 18 Factors influencing buying decisions for nicotinamide adenine dinucleotide (NAD) products
  • Fig. 19 Global nicotinamide adenine dinucleotide (NAD) products market: Product Movement Analysis, 2024 & 2033 (%)
  • Fig. 20 Oral Supplements market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Capsules/Tablets market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Powders market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Energy Drinks market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Topical Products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Creams & Serums market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Eye Cream & Lip Balms market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Global nicotinamide adenine dinucleotide (NAD) products market: Distribution Channel Movement Analysis, 2024 & 2033 (%)
  • Fig. 29 Hypermarkets & Supermarkets nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Pharmacies & Drug Stores nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Online nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Others nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Global nicotinamide adenine dinucleotide (NAD) products market: Regional outlook, 2024 & 2033 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 36 U S market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Canada market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Europe nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 U K nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Germany nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Italy nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Spain nicotinamide adenine dinucleotide (NAD) products market estimates, 2021 - 2033 (USD Million)
  • Fig. 46 China market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 India market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Japan market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Australia & New Zealand market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Taiwan market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Key company categorization
  • Fig. 55 Company market share analysis, 2024
  • Fig. 56 Strategic framework of nicotinamide adenine dinucleotide (NAD) products market